A carregar...

Controversies in the Adjuvant Therapy of High-Grade Gliomas

The 2-year survival rate of patients with glioblastoma accrued to research studies increased from 10% to nearly 40% from 2000 to 2010. These improvements began with the demonstration of a survival benefit when daily temozolomide was administered with 6 weeks of standard radiation and for 6 months th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Holdhoff, Matthias, Grossman, Stuart A.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228107/
https://ncbi.nlm.nih.gov/pubmed/21339260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0335
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!